Related Experiment Video
Updated: Dec 27, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Cardiovascular autonomic neuropathy: A silent killer with long reach
Lynn Ang1, Brendan Dillon2, Kara Mizokami-Stout1
1Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, United States of America.
Abstract:
Cardiovascular autonomic neuropathy (CAN) is a common and deadly complication of diabetes mellitus, which is frequently overlooked in clinical practice due to its characteristic subtle presentation earlier in disease. Yet, timely detection of CAN may help implementation of tailored interventions to prevent its progression and mitigate the risk of associated complications, including cardiovascular disease (CVD), cardiac arrhythmias, myocardial dysfunction leading to congestive heart failure and all-cause mortality. This review highlights current CAN epidemiology trends, novel mechanisms linking CAN with other diabetes complications and current recommendations for diagnosis and management of the disease in the clinical setting.
Insights
Cardiovascular autonomic neuropathy (CAN), a serious diabetes complication, is often missed. Early detection of CAN is crucial for interventions to prevent progression and reduce risks of heart disease and mortality.
Area of Science:
- Endocrinology
- Cardiology
- Neurology
Background:
- Cardiovascular autonomic neuropathy (CAN) is a prevalent and serious complication of diabetes mellitus.
- CAN often presents subtly, leading to delayed diagnosis and missed opportunities for intervention.
- CAN is linked to increased risks of cardiovascular disease (CVD), arrhythmias, heart failure, and mortality.
Purpose of the Study:
- To review current epidemiological trends of CAN.
- To explore novel mechanisms connecting CAN with other diabetic complications.
- To outline current diagnostic and management recommendations for CAN in clinical practice.
Main Methods:
- Literature review of current epidemiological data.
- Analysis of emerging research on pathophysiological links between CAN and diabetes complications.
- Synthesis of clinical guidelines for CAN diagnosis and management.
Main Results:
- CAN affects a significant diabetic population and contributes to substantial morbidity and mortality.
- Emerging evidence reveals intricate links between CAN and other diabetes-related conditions.
- Established diagnostic criteria and management strategies exist but require wider clinical adoption.
Conclusions:
- Timely detection and management of CAN are vital for improving outcomes in patients with diabetes.
- Further research into CAN mechanisms and effective interventions is warranted.
- Enhanced clinical awareness and adherence to guidelines can mitigate the severe consequences of CAN.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction

